Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Prevalence of Cardiovascular Risk Factors in Patients Attending General Practice Clinics in Selected Countries in the Africa and The Middle East : AFME Cardiovascular Epidemiology (ACE) Study.	Pfizer	Ongoing	N/A	4	A2581186	Dallah Hospital (Riyadh), Al Mana General Hospital (Khobar), University District Hospital (Jeddah), Al Shifa Medical Hospital (Makkah)
Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4	Roche	Ongoing	Pegasys	3	ML22728	King Abdulaziz Medical City NG (Riyadh)
Changing Diabetes® World Tour	Novonordisk	Ongoing	N/A	4	version 6 - October 2010	King Abdulaziz University Hospital (Jeddah)
An observational study to evaluate caregiver's preference and treatment outcome in patient with alzheimer's disease treated with oral or tramsdermal monotheraby - Real-World Evaluation of compliance and preference in the treatment of Alzheimer's disease(RECAP).	Novartis	Ongoing	Rivastigmine	4	CENA713D-MAX-SA-01	Dr. Soliman Fakeeh Hospital (Jeddah)
DISCOVER Study - Drug Treatment Reality of Type 2 Diabetes in Real World Settings Internationally -D1690R00002	AstraZeneca	Ongoing	N/A	4	D1690R0000	King Fahad Medical City (Riyadh), Aseer Central Hospital, King Salman Bin AbdulAziz Hospital (Riyadh), Prince Mutaib Bin Abdul Aziz Hospital (Sakaka), King Khalid University Hospital (Riyadh), Armed Forces Hospital (khamis mushait), King Abdulaziz Hospital and Oncology Center (Jeddah), King Fahad Hospital (Jeddah)
A Prospective Observational Study on the home treatment of haemarthrosis with VIIa (activated recombinant factor VII) in haemophilia A and B patient with inhibitors	Novonordisk	Ongoing	NovoSeven (activated recombinant factor VII)	4	F7HEAM-3850	King Khalid University Hospital (Riyadh)
A multicenter, observational, phase IV study of the use of Pregabalin (Nervax®) on adult patients for the management of Neuropathic pain in Saudi Arabia	Tabuk Pharmaceuticals	Ongoing	NERVAX	4	N-001	King Fahad Medical City (Riyadh)
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients	Sanofi	Ongoing	N/A	4	2	King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment	Sanofi	Ongoing	N/A	4	OBS13780	King Khalid University Hospital (Riyadh)
A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia	Tabuk Pharmaceuticals	Ongoing	Divido	4	D-001	King Fahad Medical City (Riyadh)